DoorDash, GameStop, Pfizer: What to Watch When the Stock Market Opens Today
December 09 2020 - 7:45AM
Dow Jones News
By Mischa Frankl-Duval
Here's what we are watching as markets kick into gear
Wednesday.
-- U.S. stock futures edged higher, suggesting the major indexes
may grind toward new all-time highs after the opening bell as
investors bet on fresh fiscal stimulus spending.
Futures tied to the S&P 500 ticked up 0.1%, a day after the
benchmark notched its 30th record close of 2020. Nasdaq-100 futures
were down 0.1%, indicating technology stocks may be subdued after
the New York opening bell. Read our full market wrap here.
What's Coming Up
-- DoorDash shares will begin trading today after the
food-delivery company priced its IPO at $102 apiece. That equates
to a valuation of $39 billion. DoorDash was privately valued at
more than $15 billion earlier this year.
-- Shares in software company C3.ai are also expected to start
trading today. The company priced shares at $42 apiece, above their
expected range. Advertising-software company PubMatic is also set
to float.
-- Job openings and wholesale inventories data are due at 10
a.m.
-- Adobe will give results for its most recent quarter after the
market closes.
Market Movers to Watch
-- GameStop shares fell 15% in off-hours trade after the company
released sales figures that missed analysts' expectations.
-- Insurance software company Guidewire dipped 4.3% off-hours
after its quarterly results disappointed investors.
-- United Airlines rose 1.6% in premarket trade. Boeing
yesterday delivered a 737 MAX aircraft to the carrier, which became
the first to receive a newly produced model of the jet after U.S.
regulators ended a nearly two-year grounding last month.
-- Shares in Pfizer rose 1.3% premarket. The Food and Drug
Administration yesterday said a Covid-19 vaccine the company
developed with BioNTech "met the prescribed success criteria" in a
clinical study, paving the way for the agency to green-light
distribution as early as this weekend.
-- Regenerative-medicine company Pluristem Therapeutics tumbled
more than 41% off-hours after the results of an interim analysis of
one of its treatments disappointed investors.
-- Shares in MTS Systems, a maker of test systems and industrial
sensors, were halted on news that the Amphenol, which makes
electrical communications components, would buy the company.
Must Reads Since You Went to Bed
Euro Rally Weighs on Inflation, Sapping Appetite for Stocks
Covid-19 Pandemic Puts Squeeze on Pension Plans
U.S. Job Openings Slip in Early December
Luxury Brands Follow Chinese Shoppers Back Home
U.S. Supplies of Covid-19 PPE Fall Short of Targets
Chinese Consumer Prices Show First Annual Decline Since 2009
(END) Dow Jones Newswires
December 09, 2020 08:30 ET (13:30 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
MTS Systems (NASDAQ:MTSC)
Historical Stock Chart
From Oct 2024 to Nov 2024
MTS Systems (NASDAQ:MTSC)
Historical Stock Chart
From Nov 2023 to Nov 2024